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Background
After HIV-1 fuses with the host cell, the viral core is
released into the cytoplasm and starts shedding the cap-
sid proteins (CA), a process called uncoating. Uncoating
impacts on reverse transcription, nuclear import and
integration; however, it is poorly understood.
Materials and methods
We have developed an uncoating assay using human
CD4+ T that stably express the restriction factor TRIM-
Cyp. TRIMCyp targets the HIV-1 capsid core to block
infection, however it can be specifically competed by
Cyclosporine A (CsA). By washing out CsA at different
time points in TRIMCyp expressing cells, we were able
to determine for how long after infection TRIMCyp can
target the core. We then evaluated the effect on uncoat-
ing of the drug Coumermycin-A1, which targets HIV-1
capsid and blocks integration, and the effect of Nup153,
which promotes HIV-1 nuclear import and integration.
Results
In our experimental system, HIV-1 uncoating occurred
about 100-120 min after infection. Coumermycin-A1
accelerated uncoating significantly and the effect was
capsid-dependent because the drug did not change the
kinetics of uncoating of two capsid point mutants,
N74D and A105S. Faster uncoating did not affect
reverse transcription. Experiments using the NNRTI
Nevirapine indicated that an initial uncoating step pre-
cedes reverse transcription but viral DNA synthesis
helps uncoating at a later stage, at least in a subset of
cores. Our assay revealed a degree of heterogeneity in
the kinetics of uncoating whereby most cores did not
need reverse transcription to uncoat but a subset did.
Faster uncoating induced by Coumermycin-A1 prevented
accumulation of even small amounts of HIV-1 capsid into
the nucleus of infected cells and inhibited integration.
Depletion by shRNA of nucleoporin Nup153, which is
located at the nuclear basket of the nuclear pore complex,
appeared to accelerate uncoating in CD4+ T cells, suggest-
ing that this nucleoporin might stabilize the core.
Conclusions
We have determined kinetics of HIV-1 uncoating in
human CD4+ T cells. We found that there is a heteroge-
neous population of cores that are more or less dependent
on reverse transcription for uncoating. Coumermycin-A1
appears to block HIV-1 integration by accelerating uncoat-
ing and preventing accumulation of capsid into the
nucleus. Nup153 appears to stabilise the core. Taken
together, these results suggest that small number of capsid
proteins are necessary for efficient integration and that
a final uncoating step may take place in the nucleus of
infected cells.
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